Videos

Featured

Simone Biscaglia, Ajay J Kirtane, Kendra J Grubb, et al

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

ACC 22: 3 Trials That Will Change Your Practice with Dr Purvi Parwani

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

ACC 22: Results from the PACIFIC AF Trial

Manesh R Patel,

ACC 22 Late-breaker Discussion: The PROMPT-HF Trial

Gregg C Fonarow, Tariq Ahmad, Harriette Van Spall, et al

Trending

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

George D Dangas, Adrian P Banning, Davide Cao, et al

Anushka Patel, Stephen Nicholls, Jeffrey Weitz, et al

William Fearon, Matthias Gotberg, Rafael Romaguera, et al

Carolyn Lam, Wan Azman Wan Ahmad, Azmee Modh Ghazi, et al

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

AHA 2021 Late-breaker Discussion: The EMPULSE Trial

Harriette Van Spall, ,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Events

Filter by

EuroPCR 22: DECISION QFR Shows Increased Practicability and Shorter Procedure Time for Revasc.

Taku Asano,

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

ACC 22: 3 Trials That Will Change Your Practice with Dr Purvi Parwani

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: Results From the EMPULSE Study

Mikhail Kosiborod,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

ACC 22: Results from the POISE-3 Trial

Maura Marcucci,

2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation

Michelle Kittleson,

Latest

Filter by

EuroPCR 22: DECISION QFR Shows Increased Practicability and Shorter Procedure Time for Revasc.

Taku Asano,

Simone Biscaglia, Ajay J Kirtane, Kendra J Grubb, et al

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

ACC 22: 3 Trials That Will Change Your Practice with Dr Purvi Parwani

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: Results From the EMPULSE Study

Mikhail Kosiborod,